Compare SPIR & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPIR | CYRX |
|---|---|---|
| Founded | 2012 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 826.5M | 883.3M |
| IPO Year | 2020 | 2008 |
| Metric | SPIR | CYRX |
|---|---|---|
| Price | $9.24 | $17.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $20.88 | $19.78 |
| AVG Volume (30 Days) | 510.8K | ★ 653.5K |
| Earning Date | 08-12-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 134.98 | ★ 156.22 |
| EPS | N/A | ★ N/A |
| Revenue | $110,451,000.00 | ★ $176,177,000.00 |
| Revenue This Year | $11.83 | $10.95 |
| Revenue Next Year | $24.61 | $10.11 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 13.15 | N/A |
| 52 Week Low | $6.60 | $7.61 |
| 52 Week High | $25.93 | $18.73 |
| Indicator | SPIR | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 36.06 | 56.19 |
| Support Level | $8.50 | $14.55 |
| Resistance Level | $15.07 | $18.17 |
| Average True Range (ATR) | 0.48 | 0.70 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 34.11 | 64.22 |
Spire Global Inc provides space-based data, analytics, and space services, offering datasets and insights about Earth to support decision-making. It builds, owns, and operates a constellation of nanosatellites that observe the Earth in real time using radio frequency (RF) technology. Additionally, it offers Space Services solutions that allow customers to deploy and scale their own satellite constellations using its platform, ground station network, manufacturing facilities, and launch partnerships. The company derives revenue from providing data, insights and access to its cloud-based technology platform sold on a subscription basis.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.